Newswise — JUPITER, FL – October 13, 2015 – Matthew Disney, a professor on the Florida campus of The Scripps Research Institute (TSRI), has won the prestigious 2016 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry.
The award, which was created in 2005 by Tetrahedron Publications, is given to just two individuals each year who have exhibited "exceptional creativity and dedication" in the fields of organic synthesis and bioorganic and medicinal chemistry, respectively.
“I’m honored to be recognized by Tetrahedron for our laboratory’s work,” Disney said. “The award serves as a reminder that persistence pays off. I am especially grateful to all of my co-workers who have worked diligently to push our science forward to tackle some difficult problems.”
Disney added that he is especially appreciative of the award because of his admiration for previous winners, who include TSRI’s Chair of the Department of Chemical Physiology Ben Cravatt and the late Professor Carlos Barbas III.
Tetrahedron Award winners each receive an invitation to present a plenary lecture at the annual Tetrahedron Symposium, which will be held next June in Sitges, Spain.
This latest award comes on the heels of the coveted Pioneer Award from the National Institutes of Health (NIH), which Disney received earlier this month. The Pioneer Award, which carries with it a five-year grant of $4.8 million, is intended to enable scientists to develop groundbreaking approaches with a significant impact on broad areas of biomedical science.
Tetrahedron publishes experimental and theoretical research results in the field of organic chemistry and its application to related disciplines, especially bio-organic chemistry. Areas covered by the journal include the many facets of organic synthesis, organic reactions, natural products chemistry, studies of reaction mechanisms and various aspects of spectroscopy.
About the Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including three Nobel laureates—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see www.scripps.edu/.
RSS